A multidisciplinary panel of experts provides an overview of the economic burden of HIV and the role of pre-exposure prophylaxis (PrEP) in preventing HIV transmission. Ian Frank, MD and Jeffrey ...
Real-world data show DoxyPEP implementation among PrEP users significantly reduces the incidence of chlamydia and syphilis.
HIV pre-exposure prophylaxis (PrEP) is a prevention strategy which includes the regular or event-driven use of antiretroviral medication to prevent HIV infection in adults. Several clinical trials ...
A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...
ARLINGTON, Virginia, June 11-- The HIV Medicine Association issued the following statement by Chair W. David Hardy on the U.S. Preventive Services Task Force's final pre-exposure prophylaxis ...
MONTRÉAL, March 25, 2025 /CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (PFE) and Shionogi as shareholders, is pleased to ...
The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...
HIV medication Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) will be offered free by the end of January, Prime Minister Robert Abela said on Sunday. NGOs and people living ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback